scispace - formally typeset
M

Masaharu Takigawa

Researcher at Okayama University

Publications -  381
Citations -  16788

Masaharu Takigawa is an academic researcher from Okayama University. The author has contributed to research in topics: CTGF & Chondrocyte. The author has an hindex of 67, co-authored 368 publications receiving 15664 citations. Previous affiliations of Masaharu Takigawa include Kyoto Prefectural University of Medicine & University of Tokushima.

Papers
More filters
Journal ArticleDOI

Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: A mouse fibrosis model.

TL;DR: It appears that interaction of several growth factors is required for persistent fibrotic tissue formation, with TGF‐β causing the induction and CTGF needed for maintenance of skin fibrosis.
Journal ArticleDOI

A functional polymorphism in the 5′ UTR of GDF5 is associated with susceptibility to osteoarthritis

TL;DR: It is suggested that decreased GDF5 expression is involved in the pathogenesis of osteoarthritis because of allelic differences on transcriptional activity in chondrogenic cells, with the susceptibility allele showing reduced activity.
Journal ArticleDOI

Nitric oxide mediates interleukin-1-induced gene expression of matrix metalloproteinases and basic fibroblast growth factor in cultured rabbit articular chondrocytes

TL;DR: E elevation of the NO level via iNOS mRNA expression stimulated by IL-1 mediates gene expression and production of MMPs and bFGF, resulting in the release of bF GF, and also reveal molecular mechanisms implicating the degradation of articular cartilage followed by angiogenesis in the synovium in arthritic joints.
Journal ArticleDOI

Reduction in Connective Tissue Growth Factor by Antisense Treatment Ameliorates Renal Tubulointerstitial Fibrosis

TL;DR: Findings indicate that CTGF expression in the interstitium plays a crucial role in the progression of interstitial fibrosis but not in the proliferation of tubular and interstitial cells during UUO, and may become a potential therapeutic target against tubulointerstitial fibrosis.